Full name
LIPOLEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
LIPOLEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
UL. ZŁOTA 7 / 18, 00-019 WARSZAWA
TAX ID5252534844
Rate company:
LIPOLEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
TAX ID5252534844
KRS0000426559
Share capital2,650,100.00 zł
address
UL. ZŁOTA 7 / 18, 00-019 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5252534844
REGON
146216630
KRS
0000426559
Legal form
limited liability company
Register Address
UL. ZŁOTA 7 / 18, 00-019 WARSZAWA
Date of registration in KRS
2012-07-12
Date of commencement of economic activity
2012-07-12
Act signature
RDF/371254/22/338
Pkd codes
72.11 - Research and experimental development on biotechnology
33.20.Z - Installation of industrial machinery and equipment and outfit
71.12 - Engineering activities and related technical consultancy
71.20 - Technical testing and analysis
72.19 - Other research and experimental development on natural sciences and engineering
74.1 - Specialised design activities
74.3 - Translation and interpretation activities
74.9 - Other professional, scientific and technical activities not elsewhere classified
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0 | -0 | -0 | 52,2 |
EBITDA | -0 | -0 | -0 | 52,2 |
Short time liabilities | 0 | 0 | 0 | 0 |
Equity capital | 2 | 2 | 2 | -0,1 |
Operating profit (EBIT) | -0 | -0 | -0 | 52,2 |
Assets | 2 | 2 | 2 | -0,1 |
Net profit (loss) | -0 | -0 | -0 | 52,2 |
Cash | 0,1 | 0,1 | 0,1 | -3,4 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 1,6 | 1,6 | 1,6 | -0,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -0,6 | -0,2 | -0,1 | 0,1 |
Equity capital to total assets | 100 | 100 | 100 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 0 | 0 | 0 |
Current financial liquidity indicator | 6110.21630859375 | |||
Net dept to EBITDA | 5.024451732635498 | 14.13840103149414 | 28.602872848510742 | 14,5 |
Financial statements
01-01-2021 - 31-12-2021
Annual financial report
Download xml01-01-2021 - 31-12-2021
Annual financial report
Download pdf01-01-2021 - 31-12-2021
Activity report
Download xml01-01-2021 - 31-12-2021
Resolution on profit distribution or loss coverage
Download pdf01-01-2021 - 31-12-2021
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
IK.Yniks
Ивацевичи
Molecular Biotech Mateusz Gielata
Warszawa
Mariusz Rogała
GDAŃSK
SciencePlast Sp. z o.o.
Gdansk
diagmol Łukasz Łaczmański
Wrocław